Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer

Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer

Recent therapeutic advances for managing advanced prostate cancer include the successful targeting of the androgen-AR axis with several new drugs in castrate resistant prostate cancer including abiraterone acetate and enzalutamide (MDV3100). This translational progress from “bench to bed-side” has r...

Full description

Saved in:

Bibliographic Details
Main Authors:	Manish Kohli, Rui Qin, Rafael Jimenez, Scott M. Dehm
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	Advances in Urology
Online Access:	http://dx.doi.org/10.1155/2012/781459
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Androgen Receptor-Target Genes in African American Prostate Cancer Disparities
by: Bi-Dar Wang, et al.
Published: (2013-01-01)

Calcium Activation of the Androgen Receptor in Prostate Cells
by: Zeina W. Sharawi, et al.
Published: (2023-01-01)

New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer
by: Abhijit M. Godbole, et al.
Published: (2011-01-01)

Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance
by: Caihong Li, et al.
Published: (2025-02-01)

Mathematical modeling of continuous and intermittent androgen suppression for the treatment of advanced prostate cancer
by: Alacia M. Voth, et al.
Published: (2017-05-01)

Association of Androgen-Receptor Gene Mutations with the Copy Number of Androgen-Receptor Silk Protein A Complex and Glutathione-S-Transferases T1 and M1 in Prostate Cancer Patients
by: Yan Zhang, et al.
Published: (2023-01-01)

AI-based prediction of androgen receptor expression and its prognostic significance in prostate cancer
by: Jiawei Zhang, et al.
Published: (2025-02-01)

SNP rs9364554 Modulates Androgen Receptor Binding and Drug Response in Prostate Cancer
by: Yuqian Yan, et al.
Published: (2025-01-01)

Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis
by: Renliang Yi, et al.
Published: (2016-01-01)

An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer
by: Kristene Myklak, et al.
Published: (2011-01-01)

Role of the androgen receptor in melanoma aggressiveness
by: Marzia Di Donato, et al.
Published: (2025-01-01)

High Serum Alkaline Phosphatase Flare after First-Line Androgen Deprivation Therapy Predicts Poor Prognosis in Metastatic Prostate Cancer Patients Treated with Second-Generation Androgen Receptor Targeted Therapy
by: Satoko Kojima, et al.
Published: (2021-01-01)

Relationship between androgen receptor and androgen receptor-related protein expression in breast cancers focusing on morphologically identified carcinoma with apocrine differentiation
by: Haruto Nishida, et al.
Published: (2025-01-01)

The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer
by: Jennifer H. Gunter, et al.
Published: (2012-01-01)

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer
by: Lior Z. Braunstein, et al.
Published: (2014-01-01)

Cell-specific functions of androgen receptor in skeletal muscles
by: Hiroshi Sakai, et al.
Published: (2024-05-01)

Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia
by: Yu Tong, et al.
Published: (2020-01-01)

The Prognostic Importance of Prostate-Specific Antigen in Monitoring Patients Undergoing Maximum Androgen Blockage for Metastatic Prostate Cancer
by: Ahmet Kiper, et al.
Published: (2005-01-01)

Androgen Receptor Regulates Transcription of the ZEB1 Transcription Factor
by: Bynthia M. Anose, et al.
Published: (2011-01-01)

Exploring therapeutic strategies for androgen-independent prostate cancer using a magnetic coculture platform
by: Anjani Chavali, et al.
Published: (2025-06-01)

Inhibition of Androgen Receptor Expression with Small Interfering RNA Enhances Cancer Cell Apoptosis by Suppressing Survival Factors in Androgen Insensitive, Late Stage LNCaP Cells
by: Sang Soo Kim, et al.
Published: (2013-01-01)

Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer
by: Rahul Aggarwal, et al.
Published: (2022-01-01)

A Cell Model for Conditional Profiling of Androgen-Receptor-Interacting Proteins
by: K. A. Mooslehner, et al.
Published: (2012-01-01)

CAG Expansion in Androgen Receptor Gene of Infertile Men in Erbil Governorate
by: Dashne Abdulla Salih, et al.
Published: (2023-01-01)

The Current Role of Androgen Deprivation in Patients Undergoing Dose-Escalated External Beam Radiation Therapy for Clinically Localized Prostate Cancer
by: Michael J. Smith, et al.
Published: (2012-01-01)

Corrigendum to “Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy”
by: Katherine Neubecker, et al.
Published: (2017-01-01)

Concurrent DNA hypomethylation and epigenomic reprogramming driven by androgen receptor binding in bladder cancer oncogenesis
by: Yu Xiao, et al.
Published: (2025-01-01)

The correlation between the expression of androgen receptor splice variant-7 (AR-V7) protein with the time of occurrence of castration-resistant prostate cancer and overall survival in prostate cancer in Indonesian population
by: Indrawarman Soerohardjo, et al.
Published: (2025-02-01)

Dual Functions of Androgen Receptor Overexpression in Triple-Negative Breast Cancer: A Complex Prognostic Marker
by: Umay Kiraz, et al.
Published: (2025-01-01)

Effects of IL-6 and TNF-α Cytokines on Cell Proliferation in Androgen Dependent/Independent Prostate Cancer Cell Lines
by: Serhad Onat, et al.
Published: (2024-03-01)

Long Term Progression-Free Survival in a Patient with Locally Advanced Prostate Cancer under Low Dose Intermittent Androgen Deprivation Therapy with Bicalutamide Only
by: Stefan Latz, et al.
Published: (2015-01-01)

Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer
by: Cristina Ferreira, et al.
Published: (2021-01-01)

Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation
by: Bradley A. Wall, et al.
Published: (2015-01-01)

Transmembrane Prostate Androgen-Induced Protein 1 Molecular Modeling and Refinement Using Coarse-Grained Molecular Dynamics
by: Imam Adi Wicaksono, et al.
Published: (2025-01-01)

Role of androgen receptors in sexually dimorphic phenotypes in UBE3A-dependent autism spectrum disorder
by: Yuan Tian, et al.
Published: (2025-02-01)

Reciprocal regulation between DNMT3A/3B and microRNAs miRs-299-3p/-30e is a causal factor for the downregulation of microRNAs targeting androgen receptor in prostate cancer
by: Kavya Ganapathy, et al.
Published: (2025-02-01)

Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men
by: Pedro Fernandez, et al.
Published: (2012-01-01)

Major adverse cardiovascular events among Black and White Veterans receiving androgen deprivation therapy for prostate cancer: a retrospective cohort study
by: Alexander R. Lucas, et al.
Published: (2025-02-01)

Androgens and Adipose Tissue in Males: A Complex and Reciprocal Interplay
by: Caterina Mammi, et al.
Published: (2012-01-01)

Vesicle-Associated Membrane Protein-Associated Protein A Is Involved in Androgen Receptor Trafficking in Mouse Sertoli Cells
by: Qiong Deng, et al.
Published: (2018-01-01)